87F-16054-47397
3 vaccinations
5 coded responses
35 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 221 / VA
- Registered
- 2021-01-16
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-16
Registered in v-safe
-
2021-01-16
Dose 1 — Moderna
- 2021-01-16
-
2021-01-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Itching · NoneAdult check-in
- 2021-01-19
- 2021-01-22
- 2021-01-23
- 2021-01-30
- 2021-02-08
- 2021-02-13
-
2021-02-16
Dose 2 — Moderna
-
2021-02-17
Survey response — days 1–6 daily, dose 2MedDRA: Pollakiuria — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Frequent urinationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Survey response — days 1–6 daily, dose 2MedDRA: Paraesthesia — Feeling: Fair · Site: Pain, Redness · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Mild tingling in hands ans feetMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
-
2021-03-02
Survey response — day 14, dose 2MedDRA: Cough, Fatigue, Headache, Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Cough, chest congestion, sore throat, headache, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-09
- 2021-03-18
- 2021-03-23
- 2021-03-30
- 2021-08-17
-
2021-11-07
Dose 3 — Moderna
- 2021-11-07
-
2021-11-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-09
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-11-10
- 2021-11-11
- 2021-11-13
- 2021-11-14
- 2021-11-23
- 2021-12-07
- 2021-12-14
- 2021-12-19
-
2022-02-06
Survey response — 3 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I contracted Covid 19 and so did my immediate family members.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-08
Survey response — 6 months, dose 3MedDRA: COVID-19, Dyspnoea exertional, Increased viscosity of upper respiratory secretion, Productive cough, Rhinorrhoea — Feeling: FairFree text: Since contracting Covid back in Jan I have noticed a consistent presence of mucous and/or phlem in my nasal passages and at times my chest. I also notice shortness of breath when climbing more than one flight of steps or after physical activity.MedDRA releases: 2024-11 · check-in free text available
- 2022-11-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-16 | Moderna | |
| 2 | 2021-02-16 | Moderna | |
| 3 | 2021-11-07 | Moderna | No |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Frequent urination
Systemic reaction (other): Mild tingling in hands ans feet
Release 4 — day 14, dose 2
Symptoms: Cough, chest congestion, sore throat, headache, fatigue
Release 11 — 3 months, dose 3
Symptoms: I contracted Covid 19 and so did my immediate family members.
Release 11 — 6 months, dose 3
Symptoms: Since contracting Covid back in Jan I have noticed a consistent presence of mucous and/or phlem in my nasal passages and at times my chest. I also notice shortness of breath when climbing more than one flight of steps or after physical activity.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea exertional | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Increased viscosity of upper respiratory secretion | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
| SRO | Pollakiuria | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release